Chonju, Korea, Republic of Clinical Trials

A listing of Chonju, Korea, Republic of clinical trials actively recruiting patients volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 39 clinical trials
Comparison of Laparoscopic Versus Open Gastrectomy for Gastric Cancer: A Prospective Randomized Trial

The purpose of this study is to assess the usefulness of laparoscopic surgery for gastric cancer in comparison with open gastrectomy.

gastrectomy
laparoscopy
adenocarcinoma
gastric adenocarcinoma
Keimyung University College of Medicine
 (81.2 away) Contact site
  • 14 views
  • 07 Nov, 2020
  • +9 other locations
S-1 and Irinotecan Combination Chemotherapy for Advanced Gastric Cancer

The primary goal of this phase II trial is to evaluate the response rate of combination chemotherapy with S-1 and Irinotecan in patients with advanced gastric cancer as a first-line therapy.

metastasis
neutrophil count
adenocarcinoma
capecitabine
combination chemotherapy
Chonnam National University Hwasun Hospital
 (53.4 away) Contact site
  • 13 views
  • 07 Nov, 2020
  • +5 other locations
A Clinical Trial to Evaluate the Pharmacokinetic Profiles and Safety of CKD-845

A clinical trial to evaluate the pharmacokinetic profiles and safety of CKD-845.

  • 0 views
  • 27 Jan, 2021
  • 1 location
GEN3013 Trial in Patients With Relapsed Progressive or Refractory B-Cell Lymphoma

The trial is an open-label, multi-center safety trial of epcoritamab GEN3013 (DuoBody-CD3xCD20). The trial consists of two parts: a dose escalation part phase 1, first-in-human (FIH) and an expansion part phase 2a.

renal function
anti-cd20 monoclonal antibody
cell transplantation
combination chemotherapy
ct scan
Keimyung University Dongsan Medical Center
 (81.2 away) Contact site
  • 316 views
  • 24 Feb, 2021
  • +98 other locations
Efficacy and Safety of GSK3196165 Versus Placebo and Tofacitinib in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Conventional Synthetic (cs)/Biologic (b) Disease Modifying Anti-rheumatic Drugs (DMARDs)

This study [contRAst 2 (201791: NCT03970837)] is a phase 3, randomized, multicenter, double blind study to assess the safety and efficacy of GSK3196165 in combination with csDMARD(s), for the treatment of adult participants with moderate to severe active rheumatoid arthritis (RA) who have had an inadequate response to csDMARD(s) or …

antirheumatics
sulfasalazine
arthralgia
erosion
hydroxychloroquine
GSK Investigational Site
 (38.5 away) Contact site
  • 284 views
  • 14 May, 2021
  • +223 other locations
Efficacy and Safety of Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD) With a History of Frequent Exacerbations

Phase 3 study to evaluate the efficacy and safety of a benralizumab in patients with moderate to very severe COPD with a history of frequent COPD exacerbations and elevated peripheral blood eosinophils (300/L). Eligible patients must have a history of 2 moderate and/or severe COPD exacerbations in the previous year …

severe chronic obstructive pulmonary disease
corticosteroids
eosinophil count
bronchodilator
antibiotics
Research Site
 (81.2 away) Contact site
  • 832 views
  • 02 Jun, 2021
  • +422 other locations
Safety and Efficacy of Tipifarnib in Head and Neck Cancer With HRAS Mutations and Impact of HRAS on Response to Therapy

An international, multicenter, open-label, 2 cohort, non-comparative, pivotal study evaluating the efficacy of tipifarnib in HRAS mutant HNSCC (AIM-HN). The first cohort will assess the objective response rate (ORR) of tipifarnib in subjects with HNSCC with HRAS mutations. The second study cohort, SEQ-HN, is an observational sub-study and includes 2 …

caries
neck cancer
cancer
HRAS
measurable disease
The Catholic University of Korea St. Vincent's Hospital
 (99.3 away) Contact site
  • 3 views
  • 08 Mar, 2021
  • +137 other locations
TAILored Versus COnventional AntithRombotic StratEgy IntenDed for Complex HIgh-Risk PCI

This study evaluates the efficacy and safety of tailored antithrombotic therapy with early (<6-month post-PCI) intensified (low-dose ticagrelor [120 mg loading, then 60 mg bid maintenance] and aspirin) and late (>6-month post-PCI) deescalated (clopidogrel alone) strategy in patients undergoing high-risk complex PCI as compared with standard Dual Antiplatelet Therapy(aspirin and …

diabetes
percutaneous coronary intervention
aspirin
The Catholic University of Korea, Daejeon ST. Mary's Hospital
 (38.5 away) Contact site
  • 7 views
  • 25 Jan, 2021
  • +14 other locations
Mepolizumab as Add-on Treatment IN Participants With COPD Characterized by Frequent Exacerbations and Eosinophil Level (MATINEE)

This is a multi-center, randomized, placebo-controlled, double-blind, parallel group study designed to confirm the benefits of mepolizumab treatment on moderate or severe exacerbations in COPD participants given as an add on to their optimized maintenance COPD therapy. The maximum duration of participant participation is approximately 57 weeks, consisting of 2 …

fluticasone
eosinophil count
copd exacerbation
muscarinic antagonists
antibiotics
GSK Investigational Site
 (81.2 away) Contact site
  • 379 views
  • 15 Apr, 2021
  • +204 other locations
Study to Evaluate Monotherapy and Combination Immunotherapies in Participants With PD-L1 Positive Non-small Cell Lung Cancer

This randomized phase 2 open-label study will evaluate the safety and efficacy of zimberelimab (AB122) monotherapy, domvanalimab (AB154) in combination with zimberelimab, and domvanalimab in combination with zimberelimab and etrumadenant (AB928) in front-line, PD-L1 positive, locally advanced or metastatic non-small cell lung cancer.

stage iv non-small cell lung cancer
cancer
lung carcinoma
epidermal growth factor receptor
EGFR
Hwasun, SK
 (53.1 away) Contact site
  • 61 views
  • 30 Apr, 2021
  • +130 other locations